Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Cardiac Surgery

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05462769

Enrollment

600

Registered

2022-07-18

Start date

2017-08-01

Completion date

2022-12-31

Last updated

2022-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimally Invasive Cardiac Surgery

Brief summary

A single-center prospective study. Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.

Interventions

DEVICEPercutaneous vascular closure

Percutaneous arteriotomy closed using a plug-based arteriotomy closure device

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Operated with minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden, with use of percutaneous femoral cannulation with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device.

Exclusion criteria

* None.

Design outcomes

Primary

Measure	Time frame
Any vascular groin-related complication	During the first 8 weeks after surgery

Countries

Sweden

Contacts

Primary ContactMagnus Dalén

magnus.dalen@karolinska.se+46 (0) 8 123 700 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026